Pfizer says no blindness risk from Viagra (Reuters)


Reuters - Pfizer Inc. on Monday said a
review of its popular impotence treatment Viagra turned up no
evidence of increased risk of blindness among patients taking
the erectile dysfunction drug.

Read more...